Clinical outcome after laparoscopic pure management of borderline ovarian tumors: results of a series of 34 patients

Ann Oncol. 2004 Apr;15(4):605-9. doi: 10.1093/annonc/mdh149.

Abstract

Background: The aim of this study was to assess clinical outcome after laparoscopic treatment of borderline ovarian tumor (BOT).

Patients and methods: Thirty-four patients treated initially and/or for recurrent disease using a laparoscopic approach for BOT from 1984 to January 2002.

Results: Thirty-four patients underwent laparoscopic pure treatment (without conversion by laparotomy and/or reassessment surgery by laparotomy) for BOT. Conservative treatment was performed in 31 (91%) patients. Median follow-up time was 45 months (range 6-228). Six (17%) patients recurred (in the remaining ovary following conservative surgery in five patients and in the peritoneum in one patient). Two port-site metastases were observed. None of the patients had recurrent disease in the form of ovarian carcinoma. Nine spontaneous pregnancies were observed in six patients from a group of 15 patients desiring pregnancy. All patients are alive today and disease-free.

Conclusion: These results seem to demonstrate that laparoscopic treatment can be safely performed in young patients with early stage BOT. Such a procedure is then feasible, but should be evaluated in patients with BOT and peritoneal implants.

MeSH terms

  • Adolescent
  • Adult
  • Aged
  • Female
  • Follow-Up Studies
  • Humans
  • Laparoscopy*
  • Middle Aged
  • Neoplasm Recurrence, Local
  • Neoplasm Staging
  • Ovarian Neoplasms / surgery*
  • Ovary / physiopathology
  • Ovary / surgery
  • Treatment Outcome